Stead Impact Ventures and Foundation

?? Exciting News from Cato Supply! ?? We’re thrilled to announce the expansion of our Board of Directors, bringing together industry leaders who share our mission of delivering hard to source critical medical supplies to hospitals across the U.S. With this strategic growth, Cato Supply is strengthening its commitment to innovation, reliability, and customer service—ensuring that healthcare providers have the resources they need, when they need them most. ?? Read more about our newest board members and what this means for the future of Cato Supply: https://lnkd.in/e_3mTPUT Join us in welcoming our new leadership and stay tuned for what’s next! #supplychain #Leadership #HealthcareInnovation #MedicalSupplies #healthcaresupplychain

In celebration of Caitlin’s Iowa women’s basketball jersey retirement, we are making four $22,000 grants to Iowa City area charities! These charities—University of Iowa Stead Family Children’s Hospital, Special Olympics Iowa East Central, Boys and Girls Club of the Corridor, and the Coralville Community Food Pantry—were important in Caitlin’s community giveback during her time at the University of Iowa and are closely aligned with the Caitlin Clark Foundation’s mission to uplift and inspire youth and their communities through education, nutrition, and sports. To read the full press release, visit our website in our profile.

In recent news, the FDA has granted fast track designation to Spinogenix, Inc.’s investigational therapy SPG601 for the treatment of patients with Fragile X syndrome, a leading cause of genetic #autism. To learn more, check out the article on our site! Cincinnati Children's

As 2024 draws to a close, we at ALZpath Inc. want to take a moment to reflect on a year filled with innovation, collaboration, and progress. Our journey this year wouldn’t have been possible without the incredible support of our partners, collaborators, and community. PRODUCT? Last month, our novel #pTau217 antibody was featured as one of?TIME's Best Innovations of 2024. Less than two years after our antibody technology first came to market in partnership with Quanterix, this acknowledgment underscores the impact our antibody is having on blood-based biomarker testing for early detection of Alzheimer's disease. PUBLICATIONS? Groundbreaking Research Collaborations: Our pTau217 antibody was featured in several pivotal studies this year, including the?impactful?"Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease," further solidifying its role in advancing Alzheimer’s understanding. This year,?JAMA Neurology?recognized our study,?"Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology,"?as its most-viewed paper of the year, with 141,000 views—five times more than the second most-read paper! (the?second most read paper having ~28,000 views) ??Please see a comprehensive list of publications here: https://lnkd.in/gq4SPpRX PARTNERSHIPS? ?This year we signed new licensing agreements with Beckman Coulter Diagnostics,?Roche,?Alamar Biosciences, Inc., and?Bio-Techne, showcasing our commitment to continue to drive diagnostic innovation and democratize access through collaborations with the best in the field of diagnostic technology. PEOPLE? ALZpath's leadership and scientific expertise are second to none.??To our Founders, Board of Directors, and Scientific Advisory Board, we thank you for your guidance and support in our mission to reimagine the standard of care for Alzheimer's patients through education, research, and advocacy. As we look toward 2025, we’re energized by our progress?and excited to continue building a future where early and accurate diagnosis is the norm. Here’s to another year of collaboration, innovation, and meaningful impact. #ThankYou #ALZpath #AlzheimersResearch #Innovation #TIMEBestInnovations TIME #YearInReview #Diagnostics Alzheimer's Association? Alzheimer's Drug Discovery Foundation #alzdiscovery UsAgainstAlzheimer's CEOi - Global CEO Initiative on Alzheimer's Disease (CEOi), Dr. Michelle Mielke?

Jimmy Carter will be remembered for his global impact on public health and democracy through the The Carter Center, which he and Rosalynn founded with a commitment to human rights and the alleviation of human suffering. I had the honor of working alongside Jimmy and Rosalynn, along with my Square D board, on a Habitat for Humanity International home in Kentucky. He is an inspiration for all who seek to make the world a better place for others. https://lnkd.in/gK_7-icR

In Fountain House’s new report on loneliness, Fountain House members share how the clubhouse has personally helped them to combat its effects. Hear from Kirsten and others in our full report: https://lnkd.in/ed2-FjcF